Brief: Biocept Inc Receives More Than 150,000 Samples For Covid-19 Rt-Pcr Testing To Date
Dec 14 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT INC - RECEIVED MORE THAN 150,000 SAMPLES FOR
COVID-19
RT-PCR TESTING TO DATE
* BIOCEPT INC - CONTINUED TO REPORT VAST MAJORITY OF RESULTS
TO
CUSTOMERS WITHIN 48 HOURS OF RECEIVING A SAMPLE
* BIOCEPT INC - ANNOUNCES SUCCESSFUL RELOCATION TO NEW
CORPORATE
HEADQUARTERS AND MOLECULAR LABORATORY FACILITY IN SAN DIEGO
Source text for Eikon: ID:nPnbHSj6sa
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork